PPARA and atherosclerosis: PPARα is also expressed in non-hepatic vascular cells, likely accounting for the effects of synthetic PPARα agonists on angiogenesis [21, 22], endothelial permeability [23], and vascular adhesion capacity [11], which are important in the treatment of atherosclerosis.